Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain. - Archive ouverte HAL Access content directly
Journal Articles Prostaglandins, Leukotrienes and Essential Fatty Acids Year : 2014

Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain.

(1) , (1) , (1) , (1) , (1) , (1)
1

Abstract

: 1-acetyl,2-docosahexaenoyl-glycerophosphocholine (AceDoPC) has been made to prevent docosahexaenoyl (DHA) to move to the sn-1 position as it rapidly does when present in 1-lyso,2-docosahexaenoyl-GPC (lysoPC-DHA), an efficient DHA transporter to the brain. When incubated with human blood, AceDoPC behaves closer to lysoPC-DHA than PC-DHA in terms of binding to plasma albumin and lipoproteins, and DHA incorporation into platelets and red cells. In addition, AceDoPC prevents more efficiently the deleterious effects of the experimental stroke in rats than does unesterified DHA. Also, AceDoPC inhibits platelet-activating factor-induced human blood platelet aggregation. Overall, AceDoPC might act as an efficient DHA transporter to the brain, and as a neuro-protective agent by itself.
Fichier principal
Vignette du fichier
Lagarde_et_al._PLEFA_2013-2014.pdf (192.78 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00958127 , version 1 (11-03-2014)

Identifiers

Cite

Michel Lagarde, Mayssa Hachem, Nathalie Bernoud-Hubac, Madeleine Picq, Evelyne Véricel, et al.. Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain.. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2014, 92, pp.63-65. ⟨10.1016/j.plefa.2014.01.005⟩. ⟨inserm-00958127⟩
597 View
787 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More